| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC35C2 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | MARCH10 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | WFDC6 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | NCF1 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | HGD | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | GPR25 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | NR4A1 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | FAM3B | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | ISG20 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | DNAJC5G | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
